Vita Therapeutics, Inc. — Form D
Vita Therapeutics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-29. The offering totals $20.0M, of which $20.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-01-29
- Form: D
- Accession: 0001843252-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $20.0M
- Amount sold: $20.0M
- Investors: 1
- Date of first sale: 2021-01-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-387877
Issuer
- Name: Vita Therapeutics, Inc.
- CIK: 0001843252
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 801 W. Baltimore Street, BALTIMORE, MD, 21201
- Phone: 609-339-5126
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| DAVID CHURCHILL | Director | South Burlington, VT |
| James Peyer | Director | New York, NY |
| Douglas Falk | Director | Baltimore, MD |
| Douglas Falk | Executive Officer | Baltimore, MD |
| Eva Chin | Director | Baltimore, MD |
| Mark Nuttall | Director | New York, NY |
| Vlad Coric | Director | Baltimore, MD |
| Pat LaVecchia | Director | Baltimore, MD |
| Faizzan Ahmad | Director | Baltimore, MD |
Other filings by this issuer (2)
More